Search for: "JANSSEN PHARMACEUTICALS" Results 61 - 80 of 570
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Sep 2017, 12:46 pm by Associated Press
About a dozen pharmaceutical companies, including Purdue Pharma L.P., Janssen Pharmaceuticals Inc. and Allergan PLC, filed a brief Friday saying they’ve complied with the U.S. [read post]
5 Jul 2017, 1:45 pm by Associated Press
The suit names Purdue Pharma, Endo Health Solutions, Teva Pharmaceutical Industries and subsidiary Cephalon, Johnson & Johnson and subsidiary Janssen Pharmaceuticals and Allergan. [read post]
14 Apr 2014, 7:51 am by Pete Strom
Johnson & Johnson Agrees to Settlement Talks for Topamax Lawsuits Johnson & Johnson, along with their subsidiary Janssen Pharmaceuticals, have agreed to enter settlement talks with plaintiffs in 76 Topamax personal injury lawsuits. [read post]
29 Jul 2010, 10:14 am
Johnson & Johnson has agreed to a $75 Million national settlement related to allegations that its subsidiary, Ortho-McNeil-Janssen Pharmaceuticals schemed to improperly market the drug Topamax for uses that were not approved by the Food & Drug Administration. [read post]
3 Aug 2012, 12:27 pm by Morse, Barnes-Brown Pendleton
On July 10th it was announced that MBBP client Harvard University, has entered into an agreement with Johnson & Johnson subsidiary Janssen Pharmaceuticals and Evotec, a German biotechnology company. [read post]
20 Jul 2010, 12:56 pm by mcarzima@imediainc.com
In April of 2010, Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals, both subsidiaries of Johnson & Johnson, agreed to pay over $81 million to settle criminal and civil liability claims arising from the illegal promotion of the drug Topamax. [read post]
20 Nov 2008, 4:47 pm
Alza Corp. and Janssen Pharmaceuticals, manufactured and distributed the patch. [read post]
28 Mar 2012, 6:12 pm by Mark Zamora
A jury trial is scheduled to begin Monday over accusations that a pharmaceutical company illegally marketed an anti-psychotic medication in Arkansas.Arkansas Attorney General Dustin McDaniel filed a lawsuit against Johnson & Johnson, claiming that its Janssen Pharmaceuticals subsidiary concealed the potential health risks of the drug Risperdal. [read post]
10 May 2011, 9:26 am by Bexis
William Janssen (we don't think there's any connection to Janssen Pharmaceuticals of Oxycontin fame, but we don't know for sure one way or the other). [read post]
15 Jun 2016, 7:09 am by Dr. Shezad Malik
Lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging: Continue reading [read post]
30 Dec 2016, 6:28 am by Law Offices of Jeffrey S. Glassman
  Janssen Research and Development was formerly known as Johnson and Johnson Pharmaceuticals Research and is still a wholly owned subsidiary of the pharmaceutical giant. [read post]
12 Sep 2012, 6:14 pm by Mandour & Associates
IPNews® - Johnson & Johnson unit Janssen Pharmaceuticals Inc. won a major patent infringement victory Tuesday when a New Jersey federal judge held that its patent for the popular birth control drug Ortho Tri-Cyclen Lo is valid. [read post]
4 Dec 2016, 10:11 pm by Michael Baseluos
A common misperception by the public is that a pharmaceutical manufacturer like Bayer or Janssen Pharmaceuticals (the current defendants in the multidistrict litigations in Pennsylvania and Louisiana) has a duty to warn xarelto users regarding the risks hemorrhages, strokes, and bleedouts. [read post]
7 Dec 2017, 3:09 pm by Brenda Fulmer
All three trials resulted in verdicts in favor of Janssen Pharmaceuticals and Bayer Pharmaceuticals. [read post]
2 Dec 2013, 9:11 am by Breakstone, White & Gluck
Janssen Pharmaceuticals, a unit of Johnson & Johnson, has been ordered to pay $11 million to a mother who was prescribed Topomax and gave birth to a son with a cleft lip. [read post]
6 Jun 2016, 2:51 pm by Dr. Shezad Malik
Xarelto is a new type of blood thinner approved in 2011 by the Food and Drug Administration and marketed in the U.S. by Johnson & Johnson’s subsidiary company, Janssen Pharmaceuticals. [read post]
26 Jul 2016, 6:26 pm by Dr. Shezad Malik
Xarelto is a new type of blood thinner approved in 2011 by the Food and Drug Administration and marketed in the U.S. by Johnson & Johnson’s subsidiary company, Janssen Pharmaceuticals. [read post]